• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Elevance Health Announces $640 Million Investment in Affordable Housing Over the Past Five Years, Surpassing $1 Billion in Total Commitment Nationwide

    6/17/26 10:00:00 AM ET
    $ELV
    Medical Specialities
    Health Care
    Get the next $ELV alert in real time by email

    Strategic investments support more than 40,000 housing units and advance whole health outcomes for communities across the country

    Elevance Health (NYSE:ELV) today announced it has invested $640 million in affordable housing over the past five years, building on more than $1 billion invested over nearly two decades. These investments reflect the company's continued commitment to addressing social drivers of health, helping lower the total cost of care, and expanding access to safe, stable, and affordable housing.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260617980738/en/

    Elevance Health has invested more than $1 billion across approximately 400 properties, supporting more than 40,000 housing units in 45 states, the District of Columbia, Puerto Rico, and Guam.

    Elevance Health has invested more than $1 billion across approximately 400 properties, supporting more than 40,000 housing units in 45 states, the District of Columbia, Puerto Rico, and Guam.

    Over the past five years, Elevance Health has invested $640 million across 15 properties, supporting the development of 2,654 affordable housing units, including apartment homes, townhomes, and single-family residences, across 10 states. In total, the company has invested more than $1 billion across approximately 400 properties, supporting more than 40,000 housing units in 45 states, the District of Columbia, Puerto Rico, and Guam.

    "Access to safe and stable housing is fundamental to improving health outcomes and building stronger communities," said Aimée K. Dailey, president of Government Health Benefits at Elevance Health. "Our continued investment reflects a long-term commitment to addressing the underlying factors that impact overall health. By focusing on high-impact housing initiatives and strong local partnerships, we are helping individuals and families achieve stability, improve their health, reduce avoidable healthcare costs, and create a foundation for long-term wellbeing."

    A National Commitment to Whole Health and Medicaid Populations

    Housing instability remains one of the most pressing challenges impacting health outcomes across the United States. According to the U.S. Department of Housing and Urban Development, more than 653,000 people experienced homelessness in 2023, including families with children, reflecting the growing housing challenges facing communities nationwide. For many individuals, the lack of stable housing creates significant barriers to accessing care and managing health conditions.

    Elevance Health's approach is grounded in its whole health strategy, which recognizes that social and environmental factors play a significant role in health outcomes. Housing is one of the most critical of these factors, particularly for Medicaid populations.

    Internal analysis of Elevance Health-affiliated Medicaid plan members with high healthcare utilization found that 43 percent of members with more than 50 emergency room visits per year were experiencing homelessness. This underscores the direct connection between housing instability and avoidable healthcare utilization.

    By investing in affordable housing and supportive services, Elevance Health is helping to address these challenges early and support better outcomes for the individuals and communities it serves.

    These investments reflect an evolution toward more targeted, high-impact housing developments that enable deeper community partnerships and more measurable outcomes at the local level.

    Expanding Access to Stable Housing for Vulnerable Populations

    Affordable housing plays a critical role in supporting low- to moderate-income individuals and families, including seniors, people with disabilities, and individuals experiencing or at risk of homelessness. These developments are typically designed for households earning 80 percent or less of the area median income and help ensure residents spend no more than 30 percent of their income on housing, reducing financial strain and improving overall stability.

    Elevance Health's investments are designed to support populations with complex needs, including individuals living with intellectual and or developmental disabilities, seniors on fixed incomes, and families facing housing insecurity.

    Stable housing is closely linked to improved health outcomes. Individuals with access to affordable housing are more likely to experience fewer potentially costly emergency room visits and hospitalizations, better manage chronic conditions such as diabetes, asthma, and hypertension, maintain consistent access to preventive and primary care, and achieve improved mental health outcomes.

    Conversely, housing instability is associated with higher rates of chronic illness, increased healthcare utilization, and poorer overall health outcomes. Even frequent moves can negatively impact health. Children who move multiple times within a year are more likely to experience chronic conditions and disruptions in care.

    Delivering Innovative, Community-Based Housing Solutions

    Elevance Health works through its affiliated health plans to connect members to housing resources and services that help prevent homelessness and support long-term stability.

    Across its Medicaid plans, Elevance Health supports housing programs that address barriers such as past-due rent, utility costs, and move-in expenses. Flexible funding programs help members remain housed by covering essential needs such as security deposits, overdue rent, and utility bills. These programs also connect members with housing coordinators who work directly with individuals and families to identify solutions and navigate available resources.

    In one example, flexible housing support programs have assisted approximately 1,500 households across multiple states by helping cover rent, utilities, and other essential housing-related expenses.

    Elevance Health also collaborates with community-based organizations, housing authorities, and local partners to help members access housing vouchers, prevent evictions, and secure stable housing that meets their needs. These partnerships are critical to ensuring that housing solutions are tailored to the unique needs of each community.

    Integrating Health and Community-Based Support

    In addition to supporting housing development, Elevance Health works to integrate health and social support services within communities wherever possible.

    In select markets, this includes access to healthcare and wellness programs, care coordination for individuals with complex needs, behavioral health support, and connections to food, transportation, and other essential services.

    These efforts help remove barriers to care and support individuals in managing their health more effectively. Programs that combine housing support with health and social services have demonstrated strong outcomes. In one state-based program, more than 90 percent of participating members maintained stable housing six months after receiving support.

    "Affordable housing is a critical foundation for improving quality of life and strengthening communities," said Dr. Adrienne McFadden, chief medical officer of Government Health Benefits at Elevance Health. "By working alongside community partners and aligning housing with health services, we are helping to create sustainable solutions that improve outcomes and support long-term stability."

    Looking Ahead

    Elevance Health's investments in affordable housing directly support state and community priorities, including improving population health and reducing avoidable healthcare costs.

    The company and its affiliated health plans will continue to expand its affordable housing efforts across the country, aligning investments with community needs and opportunities to improve health outcomes at scale. Through this work, the company remains focused on building healthier communities and advancing its mission to improve lives and make healthcare simpler.

    About Elevance Health

    Elevance Health is a lifetime, trusted health partner whose purpose is to improve the health of humanity. The company supports consumers, families, and communities across the entire healthcare journey – connecting them to the care, support, and resources they need to lead better lives. Elevance Health's companies serve approximately 105 million consumers through a diverse portfolio of industry-leading medical, pharmacy, behavioral, clinical, home health, and complex care solutions. For more information, please visit www.elevancehealth.com or follow us @ElevanceHealth on X and Elevance Health on LinkedIn.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20260617980738/en/

    Media Contacts:

    Elevance Health | Buddy Castellano | buddy.castellano@elevancehealth.com

    Get the next $ELV alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ELV

    DatePrice TargetRatingAnalyst
    5/20/2026$498.00Hold → Buy
    Deutsche Bank
    4/29/2026$435.00Neutral → Buy
    BofA Securities
    4/8/2026$345.00In-line
    Evercore ISI
    2/3/2026$358.00Outperform → Sector Perform
    RBC Capital Mkts
    1/8/2026$425.00Peer Perform → Outperform
    Wolfe Research
    12/19/2025$320.00Buy → Hold
    Deutsche Bank
    10/14/2025Neutral
    Goldman
    7/21/2025Buy → Hold
    Argus
    More analyst ratings

    $ELV
    SEC Filings

    View All

    SEC Form 11-K filed by Elevance Health Inc.

    11-K - Elevance Health, Inc. (0001156039) (Filer)

    6/17/26 1:58:21 PM ET
    $ELV
    Medical Specialities
    Health Care

    SEC Form 11-K filed by Elevance Health Inc.

    11-K - Elevance Health, Inc. (0001156039) (Filer)

    6/17/26 1:57:10 PM ET
    $ELV
    Medical Specialities
    Health Care

    Elevance Health Inc. filed SEC Form 8-K: Regulation FD Disclosure

    8-K - Elevance Health, Inc. (0001156039) (Filer)

    6/10/26 6:01:35 AM ET
    $ELV
    Medical Specialities
    Health Care

    $ELV
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    New Elevance Health Public Policy Institute Study Examines Payment Disputes for Planned Procedures Under the No Surprises Act

    Research finds arbitration awards for certain planned procedures are often far higher than typical in-network payment rates The No Surprises Act was created to protect patients from unexpected medical bills. While those patient protections are working, new research from the Elevance Health Public Policy Institute suggests that the law's payment dispute process is producing unexpected results for some planned medical procedures. The findings come as federal IDR volume has grown far beyond initial projections, raising concerns that a process intended as a limited payment-dispute backstop is increasingly contributing to higher out-of-network costs. The study examined more than 7,300 paym

    6/25/26 9:00:00 AM ET
    $ELV
    Medical Specialities
    Health Care

    Thomas Carr Howe Middle School Unveils New Fitness and Strength Training Space Through Partnership with Elevance Health and Impact Fitness Foundation

    Thomas Carr Howe Middle School today celebrated the unveiling of a newly transformed fitness and strength training space made possible through a partnership with Elevance Health and the Impact Fitness Foundation (IFF). The project marks the fifth consecutive year that Elevance Health and IFF have invested in Indianapolis schools through community fitness initiatives connected to the Elevance Health Women’s Fort Myers Tipoff, a premier collegiate basketball tournament that celebrates the impact of women in sports. More than 40 Elevance Health volunteers worked alongside representatives from the Impact Fitness Foundation to renovate the school’s fitness and athletic training areas, creati

    6/24/26 3:00:00 PM ET
    $ELV
    Medical Specialities
    Health Care

    Elevance Health Makes Clinical Review Faster, More Connected with Health OS

    Elevance Health today announced advancements in how it helps streamline clinical review and create a simpler, faster, and more connected experience for care providers and members through Health OS. Health OS is Elevance Health’s secure data platform designed to connect health information across electronic health records (EHRs), labs, and health information exchanges, helping support more informed and timely clinical decisions while reducing administrative burden for care providers. By connecting with healthcare data systems, including Epic’s Payer Platform, Health OS helps reduce manual steps and deliver clearer clinical insights. "Health OS represents a foundational shift in how we app

    6/23/26 8:15:00 AM ET
    $ELV
    Medical Specialities
    Health Care

    $ELV
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CAO & Controller Penczek Ronald W sold $148,766 worth of shares (369 units at $403.16), decreasing direct ownership by 9% to 3,740 units (SEC Form 4)

    4 - Elevance Health, Inc. (0001156039) (Issuer)

    6/15/26 4:10:45 PM ET
    $ELV
    Medical Specialities
    Health Care

    Director Dixon Robert L Jr sold $60,667 worth of shares (151 units at $401.77), decreasing direct ownership by 1% to 10,734 units (SEC Form 4)

    4 - Elevance Health, Inc. (0001156039) (Issuer)

    6/12/26 4:12:50 PM ET
    $ELV
    Medical Specialities
    Health Care

    CAO & Controller Penczek Ronald W exercised 1,531 shares at a strike of $294.30 and sold $617,192 worth of shares (1,531 units at $403.13) (SEC Form 4)

    4 - Elevance Health, Inc. (0001156039) (Issuer)

    5/20/26 4:11:33 PM ET
    $ELV
    Medical Specialities
    Health Care

    $ELV
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Elevance Health upgraded by Deutsche Bank with a new price target

    Deutsche Bank upgraded Elevance Health from Hold to Buy and set a new price target of $498.00

    5/20/26 8:03:29 AM ET
    $ELV
    Medical Specialities
    Health Care

    Elevance Health upgraded by BofA Securities with a new price target

    BofA Securities upgraded Elevance Health from Neutral to Buy and set a new price target of $435.00

    4/29/26 8:00:15 AM ET
    $ELV
    Medical Specialities
    Health Care

    Evercore ISI initiated coverage on Elevance Health with a new price target

    Evercore ISI initiated coverage of Elevance Health with a rating of In-line and set a new price target of $345.00

    4/8/26 8:36:16 AM ET
    $ELV
    Medical Specialities
    Health Care

    $ELV
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Collis Steven H bought $869,520 worth of shares (3,000 units at $289.84), increasing direct ownership by 469% to 3,639 units (SEC Form 4)

    4 - Elevance Health, Inc. (0001156039) (Issuer)

    3/6/26 8:03:27 AM ET
    $ELV
    Medical Specialities
    Health Care

    Director Devore Susan D. bought $374,580 worth of shares (1,200 units at $312.15), increasing direct ownership by 52% to 3,502 units (SEC Form 4)

    4 - Elevance Health, Inc. (0001156039) (Issuer)

    8/21/25 4:20:38 PM ET
    $ELV
    Medical Specialities
    Health Care

    President and CEO Boudreaux Gail bought $2,438,951 worth of shares (8,500 units at $286.94), increasing direct ownership by 6% to 151,020 units (SEC Form 4)

    4 - Elevance Health, Inc. (0001156039) (Issuer)

    7/18/25 1:42:51 PM ET
    $ELV
    Medical Specialities
    Health Care

    $ELV
    Leadership Updates

    Live Leadership Updates

    View All

    Elevance Health Announces Management Changes; CFO Mark Kaye to Expand Responsibilities to Include Carelon and Felicia Norwood to Lead Consolidated Health Benefits Organization

    Elevance Health, Inc. (NYSE:ELV) today announced management changes designed to simplify decision-making and strengthen execution across Carelon and Health Benefits. As part of these changes, Mark Kaye, Executive Vice President and Chief Financial Officer, will expand his responsibilities to include oversight of Carelon, the Company's healthcare services operations including pharmacy services, behavioral health, value-based care, and care delivery capabilities. Carelon plays a critical role in advancing the Company's strategy to lower the cost of care. Carelon's operating priorities and client commitments remain unchanged. Felicia Norwood, Executive Vice President and Chief Health Benef

    2/26/26 3:02:00 PM ET
    $ELV
    Medical Specialities
    Health Care

    Elevance Health Board Welcomes Amy Schulman as New Director, Reflecting Ongoing Commitment to Governance Excellence

    The board of directors of Elevance Health (NYSE:ELV) today announced the appointment of Amy Schulman, a recognized healthcare executive, investor, and governance leader, as an independent director, effective January 12, 2026. Schulman will serve on the Audit and Finance Committees, contributing deep expertise in healthcare innovation, regulatory strategy, and value creation across complex, global enterprises. This appointment reflects Elevance Health's ongoing board refreshment strategy to ensure diverse, independent, and future-focused leadership that aligns with the company's long-term strategy and stakeholders' priorities. "Amy's record of driving innovation, disciplined investment, an

    12/10/25 4:30:00 PM ET
    $ELV
    Medical Specialities
    Health Care

    Elevance Health Appoints Nathan Rich Vice President, Investor Relations

    Elevance Health (NYSE:ELV) announced today the appointment of Nathan Rich as Vice President, Investor Relations, effective November 11, 2024. In this role, Mr. Rich will lead Elevance Health's investor relations efforts, providing strategic leadership to support the company's growth initiatives and strengthen relationships within the investment community. He will also serve as a member of the company's executive leadership team and will report directly to Mark Kaye, Executive Vice President and Chief Financial Officer. Mr. Rich succeeds Stephen Tanal, who now serves as Chief Financial Officer for Elevance Health's Government Health Benefits business. "Nate brings nearly two decades of expe

    11/4/24 9:00:00 AM ET
    $ELV
    Medical Specialities
    Health Care

    $ELV
    Financials

    Live finance-specific insights

    View All

    Elevance Health Reports First Quarter 2026 Results; Raises Full-Year Guidance

    1Q 2026 operating revenue of $49.5 billion, up 1.5% from 1Q 2025 1Q 2026 diluted EPS1 of $8.00; adjusted diluted EPS2 of $12.58 driven by strong operating results and ~$1 per share of non-recurring investment income FY 2026 diluted EPS1 guidance to be at least $19.85, including the Company's estimate of the financial impact for the CMS matter FY 2026 adjusted diluted EPS2 guidance raised to at least $26.75, supported by underlying business strength, actions to reduce medical costs, and increased visibility Reaffirm FY 2026 operating cash flow of at least $5.5 billion, inclusive of potential cash payments for the CMS matter Returned $1.5 billion of capital to shareholders in

    4/22/26 6:00:00 AM ET
    $ELV
    Medical Specialities
    Health Care

    Elevance Health to Hold Conference Call and Webcast to Discuss First Quarter 2026 Results on April 22, 2026

    Elevance Health (NYSE:ELV) will release first quarter 2026 financial results on April 22, 2026, at 6:00 a.m. Eastern Daylight Time ("EDT"). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers: 888-947-9963 - Access Code - 3972058 (Domestic) 312-470-0178 - Access Code - 3972058 (International) 800-391-9853 - No Access Code (Domestic Replay) 203-369-3269 - No Access Code (International Replay) The call will be available through a live webcast at www.elevancehealth.com under the "Investors" link. You may also acces

    3/30/26 4:30:00 PM ET
    $ELV
    Medical Specialities
    Health Care

    Elevance Health Reports Fourth Quarter and Full Year 2025 Results; Sets Full Year 2026 Outlook

    4Q 2025 operating revenue of $49.3 billion; FY 2025 of $197.6 billion 4Q 2025 diluted EPS1 of $2.47; adjusted diluted EPS2 of $3.33 FY 2025 diluted EPS1 of $25.21; adjusted diluted EPS2 of $30.29 Projected FY 2026 GAAP diluted EPS1 to be at least $22.30 Projected FY 2026 adjusted diluted EPS2 to be at least $25.50 Returned $4.1 billion of capital to shareholders in 2025 Reaffirming long-term earnings algorithm; recalibrating segment margin targets Elevance Health, Inc. (NYSE:ELV) reported fourth quarter and full year 2025 results. "Elevance Health delivered fourth quarter results in line with our outlook, reflecting disciplined execution in a dynamic environment. As

    1/28/26 6:00:00 AM ET
    $ELV
    Medical Specialities
    Health Care

    $ELV
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Elevance Health Inc.

    SC 13G/A - Elevance Health, Inc. (0001156039) (Subject)

    11/14/24 1:22:35 PM ET
    $ELV
    Medical Specialities
    Health Care

    SEC Form SC 13G filed by Elevance Health Inc.

    SC 13G - Elevance Health, Inc. (0001156039) (Subject)

    2/14/24 10:02:59 AM ET
    $ELV
    Medical Specialities
    Health Care

    SEC Form SC 13G filed by Elevance Health Inc.

    SC 13G - Elevance Health, Inc. (0001156039) (Subject)

    2/14/23 12:37:59 PM ET
    $ELV
    Medical Specialities
    Health Care